CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Liver Cirrhosis, Alcoholic

FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING.

Drugs by status

Phase 4 trials (3)

  • propranolol
  • spironolactone
  • losartan

Phase 3 trials (1)

  • autologous dendritic cells

Phase 2 trials (6)

  • rosuvastatin
  • Filgrastim
  • resatorvid
  • allogeneic adipose derived mesenchymal stem cell
  • autologous mesenchymal stem cells
  • baclofen

Phase 1 trials (3)

  • ciprofloxacin
  • umbilical cord mesenchymal stem cells
  • autologous bone marrow derived mesenchymal cells

Other trials (2)

  • zinc
  • s-adenosyl methionine

Organizations

Organization Involved with Phase 4 Indications (3)

  • University of Southern Denmark
  • Lundbeck
  • University of Antwerp

Organization Involved with Phase 2 Indications (12)

  • Stempeutics Research Pvt Ltd
  • Sanjay Gandhi Postgraduate Institute of Medical Sciences
  • Yonsei University
  • Breach Candy Hospital, Mumbai
  • Bombay Hospital & Medical Research Center
  • Centre for Liver Research & Diagnostics, Hyderabad
  • Mediciti Hospital
  • Sahyadri Speciality Hospital
  • Ruby Hall Clinic, Pune
  • Catholic University of Sacred Heart, Rome
  • Melaka Manipal Medical College
  • Rajasthan University of Health Sciences

Organization Involved with Phase 1 Indications (4)

  • Boehringer Ingelheim
  • Pharmicell Co., Ltd.
  • University of Utah
  • University of Helsinki

Organization Involved with Other Experimental Indications (3)

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • Indiana University
  • University of Louisville

ICD-10 crosswalk

  • K70.3 — Alcoholic cirrhosis of liver

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.